DXS International plc Statement Re Award Win
2021年11月12日 - 10:00PM
RNSを含む英国規制内ニュース (英語)
TIDMDXSP
DXS INTERNATIONAL PLC
Award AQSE Company of the Year
("DXSP")
DXS International ("DXSP" or "the Company"), the AQSE Growth
Market quoted healthcare information and digital clinical decision
support systems provider, is delighted to announce that at the
ninth Annual Small Cap Awards held yesterday evening at London's
Montcalm Hotel the Company won the award for "AQSE Company of the
Year".
The Small Cap Awards shine a light on the best companies and
participants in the small and micro-cap community (sub GBP200m
market capitalisation) across nine categories. They are a
once-in-a-year opportunity to recognise outstanding achievement
focused on smaller quoted companies.
Commenting on DXS's Awards success, David Immelman, CEO of DXS
said:
"These awards are deserved recognition for the Company's
outstanding performance over the past year which has seen the
business maintain and grow its revenue and profits. I am delighted
to see the hard work of all our staff in challenging circumstances
recognised by the judging panel. The Covid-19 pandemic has added
new impetus to the realization that health care delivery is
urgently in need of a major overhaul and DXS, with deep knowledge
and experience in the electronic health care space, is
well-positioned to exploit this fast-emerging opportunity. "
The Directors of DXS International plc accept responsibility for
this announcement.
Contacts:
David Immelman (Chief Executive) 01252 719800
DXS International plc david@dxs-systems.com
https://www.dxs-systems.co.uk
Corporate Advisor
City & Merchant
David Papworth 020 7101 7676
Corporate Broker
Hybridan LLP
Claire Louise Noyce 020 3764 2341
Notes to Editors
About DXS:
DXS International presents up to date treatment guidelines and
recommendations, from Clinical Commissioning Groups and other
trusted NHS sources, to doctors, nurses and pharmacists in their
workflow and during the patient consultation. This effective
clinical decision support ultimately translates to improved
healthcare outcomes delivered more cost effectively and which
should significantly contribute towards the NHS achieving its
projected efficiency savings.
(END) Dow Jones Newswires
November 12, 2021 08:00 ET (13:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
DXS (AQSE:DXSP)
過去 株価チャート
から 5 2024 まで 6 2024
DXS (AQSE:DXSP)
過去 株価チャート
から 6 2023 まで 6 2024